HomeDNTH • NASDAQ
add
Dianthus Therapeutics Inc
Previous close
$21.35
Day range
$20.79 - $22.75
Year range
$6.58 - $33.77
Market cap
661.22M USD
Avg Volume
183.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 457.00K | -61.11% |
Operating expense | 13.41M | 13.02% |
Net income | -10.56M | -4.42% |
Net profit margin | -2.31K | -168.47% |
Earnings per share | — | — |
EBITDA | -12.94M | -21.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 173.72M | 130.12% |
Total assets | 179.40M | 115.86% |
Total liabilities | 10.54M | 11.43% |
Total equity | 168.87M | — |
Shares outstanding | 29.35M | — |
Price to book | 1.87 | — |
Return on assets | -17.42% | — |
Return on capital | -18.59% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -10.56M | -4.42% |
Cash from operations | -11.85M | -33.93% |
Cash from investing | -8.24M | 34.96% |
Cash from financing | -4.86M | — |
Net change in cash | -24.96M | -15.99% |
Free cash flow | -12.88M | — |
About
Founded
2019
Website
Employees
53
